. (ALTH)

$1.84 - (-)

Market Cap: -

As of 10/19/12 12:00 AM EDT. Market closed.

(ALTH)

. (ALTH)

$1.84
- (-)

Market Cap: -

As of 10/19/12 12:00 AM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
URL
Address
.
PRICE CHART FOR
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$1.84
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
Open
-
Previous Close
$1.84
Days Range
- - -
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
-
Dividend Yield
-
P/E
-
Shares Outstanding
0
FINANCIAL STATEMENTS FOR
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
SPECTRUM PHARMACEUTICALS INC10% OwnerSep 05, 2012 Buy$1.82130,854,840238,155,8161,000Sep 06, 2012, 05:15 PM
Warburg Pincus Private Equity VIII, L.P.DirectorSep 05, 2012 Option Exercise$1.8226,124,43047,546,4640Sep 06, 2012, 04:17 PM
TURNER JOSEPH LDirectorSep 04, 2012 Option Exercise$1.8255,000100,1000Sep 05, 2012, 04:55 PM
STOUT DAVID MDirectorSep 04, 2012 Option Exercise$1.8235,00063,7000Sep 05, 2012, 04:54 PM
LEFF JONATHAN SDirectorSep 04, 2012 Option Exercise$1.8255,000100,1000Sep 05, 2012, 04:53 PM
LATTS JEFFREYDirectorSep 04, 2012 Option Exercise$1.8255,000100,1000Sep 05, 2012, 04:52 PM
HOFFMAN STEPHEN JDirectorSep 04, 2012 Option Exercise$1.822003640Sep 05, 2012, 04:50 PM
HOFFMAN STEPHEN JDirectorSep 04, 2012 Option Exercise$1.822003640Sep 05, 2012, 04:50 PM
HOFFMAN STEPHEN JDirectorSep 04, 2012 Option Exercise$1.822003640Sep 05, 2012, 04:50 PM
HOFFMAN STEPHEN JDirectorSep 04, 2012 Option Exercise$1.822003640Sep 05, 2012, 04:50 PM
HOFFMAN STEPHEN JDirectorSep 04, 2012 Option Exercise$1.82472,871860,6250Sep 05, 2012, 04:50 PM
HOFFMAN STEPHEN JDirectorSep 04, 2012 Option Exercise$1.8292,000167,4400Sep 05, 2012, 04:50 PM
Schick Michael EVP, Sales and MarketingSep 04, 2012 Option Exercise$1.82285,113518,9060Sep 05, 2012, 04:48 PM
Morris Charles QChief Medical OfficerSep 04, 2012 Option Exercise$1.82655,0311,192,1560Sep 05, 2012, 04:47 PM
Goldsmith Bruce ASVP, Corporate DevelopmentSep 04, 2012 Option Exercise$1.82346,933631,4180Sep 05, 2012, 04:46 PM
Graboyes Marc HSVP, General CounselSep 04, 2012 Option Exercise$1.82542,028986,4910Sep 05, 2012, 04:45 PM
Clark David CVP, FinanceSep 04, 2012 Option Exercise$1.82207,114376,9470Sep 05, 2012, 04:44 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsSep 04, 2012 Option Exercise$1.82148,482270,2370Sep 05, 2012, 04:43 PM
BERNS PAUL LChief Executive OfficerSep 04, 2012 Option Exercise$1.821,233,3232,244,6480Sep 05, 2012, 04:41 PM
Schick Michael EVP, Sales and MarketingJul 11, 2012 Sale$1.786971,241285,113Jul 13, 2012, 04:40 PM
Morris Charles QChief Medical OfficerApr 27, 2012 Sale$1.817,97014,426655,031May 22, 2012, 04:49 PM
Morris Charles QChief Medical OfficerMar 01, 2012 Sale$1.4810,29215,232663,001May 22, 2012, 04:49 PM
Morris Charles QChief Medical OfficerFeb 29, 2012 Sale$1.5210,15515,478673,293May 22, 2012, 04:49 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsApr 27, 2012 Buy$1.221,1041,342148,482Apr 30, 2012, 04:59 PM
Morris Charles QChief Medical OfficerApr 27, 2012 Sale$1.817,97014,426665,323Apr 30, 2012, 04:58 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsMar 01, 2012 Sale$1.503,0254,522147,378Mar 01, 2012, 06:16 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsFeb 29, 2012 Sale$1.533,0314,623150,403Mar 01, 2012, 06:16 PM
BERNS PAUL LChief Executive OfficerMar 01, 2012 Sale$1.4821,53231,8161,233,323Mar 01, 2012, 06:15 PM
BERNS PAUL LChief Executive OfficerFeb 29, 2012 Sale$1.5221,16332,2351,254,855Mar 01, 2012, 06:15 PM
Clark David CVP, FinanceMar 01, 2012 Sale$1.503,3855,073207,114Mar 01, 2012, 06:15 PM
Clark David CVP, FinanceFeb 29, 2012 Sale$1.523,3885,165210,499Mar 01, 2012, 06:15 PM
Goldsmith Bruce ASVP, Corporate DevelopmentMar 01, 2012 Sale$1.504,4736,690346,933Mar 01, 2012, 06:14 PM
Goldsmith Bruce ASVP, Corporate DevelopmentFeb 29, 2012 Sale$1.524,5056,869351,406Mar 01, 2012, 06:14 PM
Graboyes Marc HSVP, General CounselMar 01, 2012 Sale$1.489,63514,260542,028Mar 01, 2012, 06:13 PM
Graboyes Marc HSVP, General CounselFeb 29, 2012 Sale$1.529,42514,366551,663Mar 01, 2012, 06:13 PM
Morris Charles QChief Medical OfficerFeb 29, 2012 Sale$1.5210,15515,478673,293Mar 01, 2012, 06:13 PM
Schick Michael EVP, Sales and MarketingMar 01, 2012 Sale$1.483,9605,866285,810Mar 01, 2012, 06:12 PM
Schick Michael EVP, Sales and MarketingFeb 29, 2012 Sale$1.523,8945,935289,770Mar 01, 2012, 06:12 PM
BERNS PAUL LChief Executive OfficerFeb 24, 2012 Sale$1.554,3506,743702,512Feb 27, 2012, 05:44 PM
BERNS PAUL LChief Executive OfficerFeb 23, 2012 Sale$1.569,10014,196706,862Feb 27, 2012, 05:44 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsFeb 24, 2012 Sale$1.551,4692,277109,572Feb 27, 2012, 05:43 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsFeb 23, 2012 Sale$1.584,4847,085111,041Feb 27, 2012, 05:43 PM
Goldsmith Bruce ASVP, Corporate DevelopmentFeb 24, 2012 Sale$1.54575888176,184Feb 27, 2012, 05:43 PM
Goldsmith Bruce ASVP, Corporate DevelopmentFeb 23, 2012 Sale$1.582,5003,958176,759Feb 27, 2012, 05:43 PM
Clark David CVP, FinanceFeb 24, 2012 Sale$1.55595922114,108Feb 27, 2012, 05:42 PM
Clark David CVP, FinanceFeb 23, 2012 Sale$1.571,4602,291114,703Feb 27, 2012, 05:42 PM
Schick Michael EVP, Sales and MarketingFeb 23, 2012 Sale$1.581,6452,599158,119Feb 27, 2012, 05:41 PM
Graboyes Marc HSVP, General CounselFeb 24, 2012 Sale$1.541,3802,125338,822Feb 27, 2012, 05:40 PM
Graboyes Marc HSVP, General CounselFeb 23, 2012 Sale$1.583,9506,254340,202Feb 27, 2012, 05:40 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsDec 30, 2011 Buy$1.211,1731,416115,525Jan 03, 2012, 04:42 PM
Clark David CVP, FinanceNov 16, 2011 Sale$1.43125179116,163Nov 17, 2011, 05:08 PM
Clark David CVP, FinanceNov 15, 2011 Sale$1.455,4387,861116,288Nov 17, 2011, 05:08 PM
Graboyes Marc HSVP, General CounselNov 15, 2011 Sale$1.4414,49420,900344,152Nov 17, 2011, 05:07 PM
Morris Charles QChief Medical OfficerNov 15, 2011 Sale$1.4417,82925,724441,600Nov 17, 2011, 05:06 PM
Schick Michael EVP, Sales and MarketingNov 16, 2011 Sale$1.43140201159,764Nov 17, 2011, 05:05 PM
Schick Michael EVP, Sales and MarketingNov 15, 2011 Sale$1.448,03311,576159,904Nov 17, 2011, 05:05 PM
BERNS PAUL LChief Executive OfficerNov 16, 2011 Sale$1.43450643715,962Nov 17, 2011, 05:04 PM
BERNS PAUL LChief Executive OfficerNov 15, 2011 Sale$1.4631,81746,532716,412Nov 17, 2011, 05:04 PM
Goldsmith Bruce ASVP, Corporate DevelopmentNov 16, 2011 Sale$1.43300430179,259Nov 17, 2011, 05:03 PM
Goldsmith Bruce ASVP, Corporate DevelopmentNov 15, 2011 Sale$1.4412,46518,008179,559Nov 17, 2011, 05:03 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsNov 15, 2011 Sale$1.4426,10037,707114,352Nov 17, 2011, 05:02 PM
Schick Michael EVP, Sales and MarketingJul 11, 2011 Sale$2.067301,505167,937Jul 13, 2011, 04:21 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsJun 30, 2011 Buy$1.827721,404140,452Jul 01, 2011, 05:37 PM
Morris Charles QChief Medical OfficerApr 27, 2011 Sale$2.849,80027,825459,429Apr 29, 2011, 04:43 PM
BERNS PAUL LChief Executive OfficerMar 17, 2011 Option Exercise$3.142,5007,850748,229Mar 18, 2011, 04:25 PM
Graboyes Marc HSVP, General CounselFeb 24, 2011 Sale$3.131,4104,406187,843Feb 25, 2011, 05:29 PM
Graboyes Marc HSVP, General CounselFeb 23, 2011 Sale$3.243,80012,318189,253Feb 25, 2011, 05:29 PM
Clark David CVP, FinanceFeb 24, 2011 Sale$3.125571,74067,769Feb 25, 2011, 05:28 PM
Clark David CVP, FinanceFeb 23, 2011 Sale$3.251,3654,43968,326Feb 25, 2011, 05:28 PM
BERNS PAUL LChief Executive OfficerFeb 24, 2011 Sale$3.124,25513,293399,787Feb 25, 2011, 05:28 PM
BERNS PAUL LChief Executive OfficerFeb 23, 2011 Sale$3.259,19329,878404,042Feb 25, 2011, 05:28 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsFeb 24, 2011 Sale$3.201,4694,70195,915Feb 25, 2011, 05:27 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsFeb 23, 2011 Sale$3.234,48414,48697,384Feb 25, 2011, 05:27 PM
Schick Michael EVP, Sales and MarketingFeb 23, 2011 Sale$3.251,5705,105103,667Feb 25, 2011, 05:26 PM
Goldsmith Bruce AVP, Corporate DevelopmentFeb 24, 2011 Sale$3.125071,583124,726Feb 25, 2011, 05:25 PM
Goldsmith Bruce AVP, Corporate DevelopmentFeb 23, 2011 Sale$3.252,2507,313125,233Feb 25, 2011, 05:25 PM
BENNETT BRUCE K JRVP, Pharmaceutical OperationsDec 31, 2010 Buy$3.923331,305101,868Jan 04, 2011, 04:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
SPECTRUM PHARMACEUTICALS INC10% Owner09/05/2012238,155,816
Warburg Pincus Private Equity VIII, L.P.Director09/05/201247,546,464
TURNER JOSEPH LDirector09/04/2012100,100
STOUT DAVID MDirector09/04/201263,700
LEFF JONATHAN SDirector09/04/2012100,100
LATTS JEFFREYDirector09/04/2012100,100
HOFFMAN STEPHEN JDirector09/04/2012364
HOFFMAN STEPHEN JDirector09/04/2012364
HOFFMAN STEPHEN JDirector09/04/2012364
HOFFMAN STEPHEN JDirector09/04/2012364
HOFFMAN STEPHEN JDirector09/04/2012860,625
HOFFMAN STEPHEN JDirector09/04/2012167,440
Schick Michael EVP, Sales and Marketing09/04/2012518,906
Morris Charles QChief Medical Officer09/04/20121,192,156
Goldsmith Bruce ASVP, Corporate Development09/04/2012631,418
Graboyes Marc HSVP, General Counsel09/04/2012986,491
Clark David CVP, Finance09/04/2012376,947
BENNETT BRUCE K JRVP, Pharmaceutical Operations09/04/2012270,237
BERNS PAUL LChief Executive Officer09/04/20122,244,648
Schick Michael EVP, Sales and Marketing07/11/20121,241
Morris Charles QChief Medical Officer04/27/201214,426
Morris Charles QChief Medical Officer03/01/201215,232
Morris Charles QChief Medical Officer02/29/201215,478
BENNETT BRUCE K JRVP, Pharmaceutical Operations04/27/20121,342
Morris Charles QChief Medical Officer04/27/201214,426
BENNETT BRUCE K JRVP, Pharmaceutical Operations03/01/20124,522
BENNETT BRUCE K JRVP, Pharmaceutical Operations02/29/20124,623
BERNS PAUL LChief Executive Officer03/01/201231,816
BERNS PAUL LChief Executive Officer02/29/201232,235
Clark David CVP, Finance03/01/20125,073
Clark David CVP, Finance02/29/20125,165
Goldsmith Bruce ASVP, Corporate Development03/01/20126,690
Goldsmith Bruce ASVP, Corporate Development02/29/20126,869
Graboyes Marc HSVP, General Counsel03/01/201214,260
Graboyes Marc HSVP, General Counsel02/29/201214,366
Morris Charles QChief Medical Officer02/29/201215,478
Schick Michael EVP, Sales and Marketing03/01/20125,866
Schick Michael EVP, Sales and Marketing02/29/20125,935
BERNS PAUL LChief Executive Officer02/24/20126,743
BERNS PAUL LChief Executive Officer02/23/201214,196
BENNETT BRUCE K JRVP, Pharmaceutical Operations02/24/20122,277
BENNETT BRUCE K JRVP, Pharmaceutical Operations02/23/20127,085
Goldsmith Bruce ASVP, Corporate Development02/24/2012888
Goldsmith Bruce ASVP, Corporate Development02/23/20123,958
Clark David CVP, Finance02/24/2012922
Clark David CVP, Finance02/23/20122,291
Schick Michael EVP, Sales and Marketing02/23/20122,599
Graboyes Marc HSVP, General Counsel02/24/20122,125
Graboyes Marc HSVP, General Counsel02/23/20126,254
BENNETT BRUCE K JRVP, Pharmaceutical Operations12/30/20111,416
Clark David CVP, Finance11/16/2011179
Clark David CVP, Finance11/15/20117,861
Graboyes Marc HSVP, General Counsel11/15/201120,900
Morris Charles QChief Medical Officer11/15/201125,724
Schick Michael EVP, Sales and Marketing11/16/2011201
Schick Michael EVP, Sales and Marketing11/15/201111,576
BERNS PAUL LChief Executive Officer11/16/2011643
BERNS PAUL LChief Executive Officer11/15/201146,532
Goldsmith Bruce ASVP, Corporate Development11/16/2011430
Goldsmith Bruce ASVP, Corporate Development11/15/201118,008
BENNETT BRUCE K JRVP, Pharmaceutical Operations11/15/201137,707
Schick Michael EVP, Sales and Marketing07/11/20111,505
BENNETT BRUCE K JRVP, Pharmaceutical Operations06/30/20111,404
Morris Charles QChief Medical Officer04/27/201127,825
BERNS PAUL LChief Executive Officer03/17/20117,850
Graboyes Marc HSVP, General Counsel02/24/20114,406
Graboyes Marc HSVP, General Counsel02/23/201112,318
Clark David CVP, Finance02/24/20111,740
Clark David CVP, Finance02/23/20114,439
BERNS PAUL LChief Executive Officer02/24/201113,293
BERNS PAUL LChief Executive Officer02/23/201129,878
BENNETT BRUCE K JRVP, Pharmaceutical Operations02/24/20114,701
BENNETT BRUCE K JRVP, Pharmaceutical Operations02/23/201114,486
Schick Michael EVP, Sales and Marketing02/23/20115,105
Goldsmith Bruce AVP, Corporate Development02/24/20111,583
Goldsmith Bruce AVP, Corporate Development02/23/20117,313
BENNETT BRUCE K JRVP, Pharmaceutical Operations12/31/20101,305
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR
LOADING...